Institutional investors purchased a net $3.4 million shares of MDCO during the quarter ended June 2014 and now own 104.58% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TRUENORTH, INC. Bought 107.4 Thousand shares of Medicines Co
QUANTBOT TECHNOLOGIES LLC Bought 41.9 Thousand shares of Medicines Co
HSBC GLOBAL ASSET MANAGEMENT (DE... Bought 3.0 Thousand shares of Medicines Co